Psoriasis Research and Treatment Center (PRTC)
Director: Priv.-Doz. Dr. med. Robert Sabat
The PRTC is dedicated to research into the pathogenesis of chronic inflammatory skin diseases such as Psoriasis and Acne inversa/Hidradenitis suppurativa, the development of new therapy concepts, and the optimal medical care for the patients.
You are here:
The Psoriasis Research and Treatment Center (PRTC) is an interdisciplinary center at the Clinic of Dermatology, Venereology, and Allergology and the Institute of Medical Immunology, Charité. The Center focuses on chronic inflammatory diseases, in particular Psoriasis and Acne inversa/Hidradentitis suppurativa.
The main goals are to elucidate the pathogenesis of the diseases and to develop innovative therapeutic concepts. The center also offers special consultation hours for patients with Psoriasis and Acne inversa.
The PRTC currently consists of approximately 20 employees with scientific and/or clinical backgrounds. Their interdisciplinary cooperation ensures a high level of synergy and translation.
The concept of the PRTC is reflected in its structure, which covers three working foci:
- Patient care
- Clinical research
- Experimental research
Contact
Leitung Psoriasis Forschungs- und BehandlungsCentrums
Leitung Experimentelle Forschung
Leitung Klinische Forschung und Patientenversorgung (Acne Inversa & Psoriasis)
Cooperation partners and sponsors of the PRTC
Cooperation Partners (Selection)
- BIH Center for Regenerative Medicine and Berlin Center for Advanced Therapies, Charité
- Institute for Virology, Charité
- Medical Clinic for Gastroenterology, Infectiology and Rheumatology, Charité
- Clinic for Dermatology, Venereology and Allergology, University of Göttingen
- Clinic and Polyclinic for Dermatology and Allergology, University of Bonn
- Center for Translational Medicine, University Hospital, Ruhr University Bochum
- Institute for Experimental Dermatology, University Hospital Schleswig Holstein
- Clinic and Polyclinic for Dermatology and Venereology, University of Rostock
- Institute for Immunology of the Veterinary Medicinal Faculty, University Leipzig
- Clinic and Polyclinic for Dermatology, Venereology and Allergology, University Clinic Leipzig
- CECAD Research Center, Institute for Genetics, University of Cologne
- Sanofi-Aventis Germany GmbH, Frankfurt
- Bayer Schering Pharma AG, Berlin
- Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach
- Department of Dermatology, Boston University
- Laboratory for Investigative Dermatology, The Rockefeller University, New York
- 4th Clinic for Internal Medicine, University Medicine, Athens
- Centre de Recherche en Transplantation et Immunologie, University of Nantes
- Groupe de Recherche sur l'Adaptation Microbienne, University Caen Normandie, Caen
Financial support of the center (experimental and clinical research; selection)
- Federal Ministry of Education and Research (BMBF)
- German Research Foundation (DFG)
- Charité Research Organization GmbH (CRO)
- Parexel International GmbH
- Novartis Pharma GmbH
- AbbVie Inc. und AbbVie Germany GmbH & Co. KG
- Sanofi-Aventis Germany GmbH
- Jannssen-Cilag GmbH
- Bayer AG
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Celgene GmbH
- Dr. Wilmar Schwabe GmbH & Co. KG
- Floxopharm GmbH &Co. KG
- Pfizer Deutschland GmbH
- UCB Biopharma SPRL
- Biogen IDEC GmbH
- UCB Biopharma SPRL
- LEO Pharma GmbH
- Lilly Pharma GmbH
- Pfizer Deutschland GmbH
- GloxoSmithKline GmbH & Co. KG